Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis

Published:2014-12 Issue:1 Volume:15 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Hostettler Katrin E,Zhong Jun,Papakonstantinou Eleni,Karakiulakis George,Tamm Michael,Seidel Petra,Sun Qingzhu,Mandal Jyotshna,Lardinois Didier,Lambers Christopher,Roth Michael

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1186/s12931-014-0157-3/fulltext.html

Reference39 articles.

1. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001, 134 (2): 136-151. 10.7326/0003-4819-134-2-200101160-00015.

2. Bonner JC: Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004, 15 (4): 255-273. 10.1016/j.cytogfr.2004.03.006.

3. Zhuo Y, Zhang J, Laboy M, Lasky JA: Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2004, 286 (1): L182-L188. 10.1152/ajplung.00083.2003.

4. Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S: Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2005, 171 (11): 1279-1285. 10.1164/rccm.200404-531OC.

5. Inoue Y, King TE, Barker E, Daniloff E, Newman LS: Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2002, 166 (5): 765-773. 10.1164/rccm.2010014.

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic mechanisms and latest therapeutic approaches for radiation-induced lung injury: A narrative review;Critical Reviews in Oncology/Hematology;2024-10

2. Epithelial–mesenchymal transition in chemoradiation‐induced lung damage: Mechanisms and potential treatment approaches;Journal of Biochemical and Molecular Toxicology;2024-08

3. A Jaw-Dropping Consequence: Nintedanib’s Role in Osteonecrosis of the Jaw;Cureus;2024-07-29

4. Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluation;Drug Development and Industrial Pharmacy;2024-07-02

5. Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins;Medicina;2024-06-27